Literature DB >> 9175026

Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins.

R H Scofield1, B T Kurien, M Reichlin.   

Abstract

A pair of monozygotic twins with Sjögren's syndrome are described who both have large amounts of anti-Ro/SSA in their sera by ELISA, but no precipitin in double immunodiffusion. Unique among previously encountered specimens, sera from the twins inhibit the formation of Ro/SSA-precipitins in double immunodiffusion by known anti-Ro/SSA positive SLE patients. The twins have near identical, clonally restricted anti-Ro/SSA autoantibodies as evaluated by isoelectric focusing and bind the same 60 kD Ro/SSA peptides. Thus, this pair of monozygotic twins has an identical fine specificity in their immune response to 60 kD Ro/SSA, despite potential differences in their immune response generated by random processes in the formation of immunoglobulin molecules and T cell receptors. These data imply that the anti-Ro/SSA found in these sera binds less than three epitopes such that soluble antigen/antibody complexes are formed instead of an insoluble complex that precipitates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175026     DOI: 10.1177/096120339700600409

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

Review 1.  Genetics of Sjögren's syndrome in the genome-wide association era.

Authors:  John A Ice; He Li; Indra Adrianto; Paul Chee Lin; Jennifer A Kelly; Courtney G Montgomery; Christopher J Lessard; Kathy L Moser
Journal:  J Autoimmun       Date:  2012-01-29       Impact factor: 7.094

2.  Like father, like son.

Authors:  Jeffrey Lee; Peter Merry; Richard Ball; Karl Gaffney
Journal:  Ann Rheum Dis       Date:  2007-12       Impact factor: 19.103

Review 3.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

4.  Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.

Authors:  Biji T Kurien; Andrew Porter; Yaser Dorri; Saqib Iqbal; Anil D'Souza; Anil Singh; Sima Asfa; Marc Cartellieri; Kristen Mathias; Hiroyuki Matsumoto; Michael Bachmann; Kenneth Hensley; R Hal Scofield
Journal:  Free Radic Biol Med       Date:  2010-10-12       Impact factor: 7.376

Review 5.  Genetics of systemic lupus erythematosus and Sjögren's syndrome.

Authors:  R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 6.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

7.  Genetics and epigenetics in primary Sjögren's syndrome.

Authors:  Juliana Imgenberg-Kreuz; Astrid Rasmussen; Kathy Sivils; Gunnel Nordmark
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

Review 8.  Genetic aspects of Sjögren's syndrome.

Authors:  Anne I Bolstad; Roland Jonsson
Journal:  Arthritis Res       Date:  2002-09-24

9.  Familial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Ana M Valdes; Lai-Chu See; Shue-Fen Luo; Kuang-Hui Yu; Weiya Zhang; Michael Doherty
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

Review 10.  Interferons in Sjögren's Syndrome: Genes, Mechanisms, and Effects.

Authors:  He Li; John A Ice; Christopher J Lessard; Kathy L Sivils
Journal:  Front Immunol       Date:  2013-09-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.